Chander Avinash, Sen Namita, Naidu Devendra G, Spitzer Alan R
Department of Pediatrics, Division of Neonatology, State University of New York, Stony Brook, NY 11794-8111, USA.
Cell Calcium. 2003 Jan;33(1):11-7. doi: 10.1016/s0143-4160(02)00177-x.
The fusion of lamellar body with plasma membrane, a distal obligatory step in exocytosis of lung surfactant, may be mediated by annexin a7 (anx a7; synexin). To understand the mechanism of anx a7 action, we tested the hypothesis that anx a7 binding to membranes would increase in order to facilitate membrane fusion during stimulation of lung surfactant secretion. Isolated rat alveolar type II cells were treated with established secretagogues of lung surfactant and the membrane and cytosol fractions were analyzed for in vitro binding of anx a7. In cells treated with calcium ionophore (A23187) or phorbol 12-myristate 13-acetate (PMA), anx a7 binding to the membrane fraction was increased by 120%, while that to the cytosol fraction was decreased by 40%, when compared with binding to corresponding fractions from control cells. Protein kinase inhibitors prevented the PMA effects on anx a7 binding. The lamellar body and plasma membrane fractions of A23187-treated cells also showed increased binding of anx a7. The lamellar bodies of A23187-treated cells showed lower K(m) for Ca(2+) and higher maximal binding of anx a7, when compared with those from control cells. Collectively, our findings suggest that these two agents modify membrane proteins to regulate anx a7 binding, which may facilitate increased membrane fusion activity during stimulation of surfactant secretion.
板层小体与质膜融合是肺表面活性剂胞吐作用的一个远端必要步骤,可能由膜联蛋白A7(AnxA7;连接蛋白)介导。为了解AnxA7的作用机制,我们检验了这样一个假设,即在刺激肺表面活性剂分泌过程中,AnxA7与膜的结合会增加,以促进膜融合。用既定的肺表面活性剂促分泌剂处理分离的大鼠肺泡II型细胞,并分析膜和胞质部分AnxA7的体外结合情况。与对照细胞相应部分的结合相比,用钙离子载体(A23187)或佛波酯12-肉豆蔻酸酯13-乙酸酯(PMA)处理的细胞中,AnxA7与膜部分的结合增加了120%,而与胞质部分的结合减少了40%。蛋白激酶抑制剂可阻止PMA对AnxA7结合的影响。A23187处理细胞的板层小体和质膜部分也显示出AnxA7结合增加。与对照细胞相比,A23187处理细胞的板层小体对Ca(2+)的K(m)较低,AnxA7的最大结合较高。总的来说,我们的研究结果表明,这两种试剂可修饰膜蛋白以调节AnxA7结合,这可能有助于在刺激表面活性剂分泌过程中增加膜融合活性。